PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Label - IM-4456
100 mL
NDC 0409-7811-31
METRONIDazole
Injection, USP
500 mg/100 mL (5 mg/mL)
EACH mL CONTAINS METRONIDAZOLE 5 mg;
SODIUM CHLORIDE 7.9 mg; DIBASIC SODIUM
PHOSPHATE, ANHYDROUS 0.48 mg; CITRIC ACID,
ANHYDROUS 0.23 mg. SODIUM 14 mEq/100 mL.
314 mOsmol/LITER (CALC.). pH 5.8 (4.5 to 7.0).
ADDITIVES SHOULD NOT BE MADE TO THIS SOLUTION.
DO NOT REFRIGERATE
SINGLE-DOSE CONTAINER. FOR INTRAVENOUS USE.
USUAL DOSAGE: SEE INSERT. STERILE, NONPYROGENIC.
PROTECT FROM LIGHT. USE ONLY IF SOLUTION IS CLEAR
AND CONTAINER IS UNDAMAGED. MUST
NOT BE USED IN SERIES CONNECTIONS.
RX ONLY
DISTRIBUTED BY HOSPIRA, INC.,
LAKE FOREST,
IL 60045 USA
3
V
CONTAINS DEHP
IM-4456
14480101
PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Pouch - WR-0585
TO OPEN – TEAR AT NOTCH
NDC 0409-7811-31
One Unit
METRONIDazole
Injection, USP
Rx only
500 mg/100 mL (5 mg/mL)
Each mL contains metronidazole 5 mg; sodium chloride 7.9 mg; dibasic sodium
phosphate, anhydrous 0.48 mg; citric acid, anhydrous 0.23 mg. Sodium 14 mEq/100 mL.
314 mOsmol/liter (CALC.). pH 5.8 (4.5 to 7.0).
ADDITIVES SHOULD NOT BE MADE TO THIS SOLUTION
DO NOT REFRIGERATE
Single-dose container. For intravenous use. Usual dose: See insert. Sterile, nonpyrogenic.
Protect from light. Use only if solution is clear. After removing the overwrap, check
for minute leaks by squeezing container firmly. If leaks are found, discard unit as
sterility may be impaired. Must not be used in series connections.
The overwrap is a moisture barrier. Do not remove unit from overwrap until ready for
use. Use unit promptly when pouch is opened. Store at 20 to 25°C (68 to 77°F). [See
USP Controlled Room Temperature.] Protect from freezing. See insert.
F WR-0585
Hospira
Not Made With Natural Rubber Latex
14480201
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Label - IM-4457
100 mL
NDC 0409-7811-11
METRONIDazole
Injection, USP
500 mg/100 mL (5 mg/mL)
EACH mL CONTAINS METRONIDAZOLE 5 mg;
SODIUM CHLORIDE 7.9 mg; DIBASIC SODIUM
PHOSPHATE, ANHYDROUS 0.48 mg; CITRIC ACID,
ANHYDROUS 0.23 mg. SODIUM 14 mEq/100 mL.
314 mOsmol/LITER (CALC.). pH 5.8 (4.5 to 7.0).
ADDITIVES SHOULD NOT BE MADE TO THIS SOLUTION.
DO NOT REFRIGERATE
SINGLE-DOSE CONTAINER. FOR INTRAVENOUS USE.
USUAL DOSAGE: SEE INSERT. STERILE, NONPYROGENIC.
PROTECT FROM LIGHT. USE ONLY IF SOLUTION IS CLEAR
AND CONTAINER IS UNDAMAGED. MUST
NOT BE USED IN SERIES CONNECTIONS.
RX ONLY
DISTRIBUTED BY HOSPIRA, INC.,
LAKE FOREST,
IL 60045 USA
3
V
CONTAINS DEHP
IM-4457
14479801
PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Pouch - WR-0586
TO OPEN — TEAR AT NOTCH
NDC 0409-7811-32
Contains Four Units of NDC 0409-7811-11
METRONIDazole
Injection, USP
Rx only
500 mg/100 mL (5 mg/mL)
Each mL contains metronidazole 5 mg; sodium chloride 7.9 mg; dibasic sodium
phosphate, anhydrous 0.48 mg; citric acid, anhydrous 0.23 mg. Sodium 14 mEq/100 mL.
314 mOsmol/liter (CALC.). pH 5.8 (4.5 to 7.0).
ADDITIVES SHOULD NOT BE MADE TO THIS SOLUTION.
DO NOT REFRIGERATE
Single-dose container. For intravenous use. Usual dose: See insert. Sterile,
nonpyrogenic. Protect from light. Use only if solution is clear. After removing
the overwrap, check for minute leaks by squeezing container firmly. If leaks are
found, discard unit as sterility may be impaired. Must not be used in series
connections.
The overwrap is a moisture barrier. Do not remove unit from overwrap until ready
for use. Use unit promptly when pouch is opened. Store at 20 to 25°C (68 to 77°F).
[See USP Controlled Room Temperature.] Protect from freezing. See insert.
Not Made With Natural Rubber Latex
Distributed by Hospira, Inc.,
Lake Forest, IL 60045 USA
F WR-0586
Hospira
14479901
